103 research outputs found
Molecular characterisation of a gene trap integration into the Aminopeptidase O (ApO) gene
The protease aminopeptidase O (ApO) was isolated during a gene trap
screen designed to identify novel developmentally regulated genes involved in
cardiovascular development. The aims of this thesis were to characterise the
gene trap integration, determine the full-length open reading frame (ORF) and
to investigate any functional domains that the gene contained. Additionally,
germline transmission of the gene trap demonstrated expression in the
vasculature of mice. Work was undertaken to investigate if there was a
phenotype in the homozygous gene trap mice with particular emphasis on
whether this gene was involved in the process of new blood vessel formation
(angiogenesis).Initially, 5' RACE (Rapid Amplification of cDNA Ends) generated a 206
bp sequence that aligned with expressed sequence tag data to build a contig
with a partial ORF of 177 amino acids. Additional rounds of 5'RACE
generated a full length open reading frame of 823 amino acids. The nucleotide
and protein sequence are highly conserved between mouse, rat and human.
The gene encodes a catalytic domain characteristic of the Ml family of
aminopeptidases and contains a C-terminal armadillo repeat sequence and a
putative nuclear localisation signal (NLS). The NLS was experimentally
confirmed by transfection of eGFP-ApO constructs demonstrating that the
signal localised the fusion protein to the nucleoli.The gene trap ES cells were injected into blastocysts and transmitted
through the germline. Generation of homozygous animals resulted in normal,
healthy, viable mice with no apparent phenotype. Expression analysis by lacZ
staining and RNA in situ indicated that ApO expression was restricted to the
cardiovasculature of embryos and adult tissues. The possibility that the ApO
may be involved in the process of angiogenesis was investigated using the
aortic ring assay. Northern blot analysis has shown that there are tissue
specific isoforms and RT-PCR analysis has revealed that the catalytic domain
and nuclear localisation signal can be removed by alternative splicing. An
antibody was raised against purified full length murine APO protein and the
immunopurified antibody tested by Western blot, immunoprecipitation and
immunohistochemistry
Modulation of Aplnr signaling is required during the development and maintenance of the hematopoietic system
A human iPSC line capable of differentiating into functional macrophages expressing ZsGreen: a tool for the study and in vivo tracking of therapeutic cells
We describe the production of a human induced pluripotent stem cell (iPSC) line, SFCi55-ZsGr, that has been engineered to express the fluorescent reporter gene, ZsGreen, in a constitutive manner. The CAG-driven ZsGreen expression cassette was inserted into the AAVS1 locus and a high level of expression was observed in undifferentiated iPSCs and in cell lineages derived from all three germ layers including haematopoietic cells, hepatocytes and neurons. We demonstrate efficient production of terminally differentiated macrophages from the SFCi55-ZsGreen iPSC line and show that they are indistinguishable from those generated from their parental SFCi55 iPSC line in terms of gene expression, cell surface marker expression and phagocytic activity. The high level of ZsGreen expression had no effect on the ability of macrophages to be activated to an M(LPS + IFNγ), M(IL10) or M(IL4) phenotype nor on their plasticity, assessed by their ability to switch from one phenotype to another. Thus, targeting of the AAVS1 locus in iPSCs allows for the production of fully functional, fluorescently tagged human macrophages that can be used for in vivo tracking in disease models. The strategy also provides a platform for the introduction of factors that are predicted to modulate and/or stabilize macrophage function.
This article is part of the theme issue ‘Designer human tissue: coming to a lab near you’
Single cell analyses and machine learning define hematopoietic progenitor and HSC-like cells derived from human PSCs
Haematopoietic stem and progenitor cells (HSPCs) develop through distinct waves at various anatomical sites during embryonic development. The in vitro differentiation of human pluripotent stem cells (hPSCs) is able to recapitulate some of these processes, however, it has proven difficult to generate functional haematopoietic stem cells (HSCs). To define the dynamics and heterogeneity of HSPCs that can be generated in vitro from hPSCs, we exploited single cell RNA sequencing (scRNAseq) in combination with single cell protein expression analysis. Bioinformatics analyses and functional validation defined the transcriptomes of naïve progenitors as well as erythroid, megakaryocyte and leukocyte-committed progenitors and we identified CD44, CD326, ICAM2/CD9 and CD18 as markers of these progenitors, respectively. Using an artificial neural network (ANN), that we trained on a scRNAseq derived from human fetal liver, we were able to identify a wide range of hPSCs-derived HPSC phenotypes, including a small group classified as HSCs. This transient HSC-like population decreased as differentiation proceeded and was completely missing in the dataset that had been generated using cells selected on the basis of CD43expression. By comparing the single cell transcriptome of in vitro-generated HSC-like cells with those generated within the fetal liver we identified transcription factors and molecular pathways that can be exploited in the future to improve the in vitro production of HSCs
Manipulating transcription factors in human induced pluripotent cell-derived cells to enhance the production and the maturation of red blood cells
The most widely transfused blood component is red blood cells (RBCs), and voluntary
donation is the main resource for RBC transfusion. In the UK, 7,000 units of RBCs
are transfused daily but this life-saving cell therapy is completely dependent on donors
and there are persistent problems associated with transfusion transmitted infections
and in blood group compatibility. Furthermore, the quality, safety and efficiency of
donated RBCs gradually decrease with storage time. A number of novel sources of
RBCs are being explored including the production of RBCs from adult haematopoietic
progenitor cells, erythroid progenitor cell lines and induced pluripotent stem cells
(iPSCs). The iPSC source could essentially provide a limitless supply and a route to
producing cells that are matched to the recipient. A number of protocols have been
described to produce mature RBCs from human pluripotent stem cells but they are
relatively inefficient and would be difficult to scale up to the levels required for clinical
translation.
We tested and evaluated a defined feeder- and serum-free differentiation protocol for
deriving erythroid cells from hiPSCs. RBC production was not efficient, the cells that
were produced did not enucleate efficiently and they expressed embryonic rather than
adult globin. We hypothesised that the production of RBCs from iPSCs could be
enhanced by enforced expression of erythroid-specific transcription factors (TFs).
Previous studies had demonstrated that Krüppel-like factor 1 (KLF1) plays an
important role in RBC development and maturation so we generated iPSC lines
expressing a tamoxifen-inducible KLF1-ERT2 fusion protein. Using zinc finger
nuclease technology, we targeted the expression cassette to the AAVS1 locus to ensure
consistent expression levels and to avoid integration site specific effects and/or
silencing. These iKLF1 iPSCs were applied to our defined RBC differentiation
protocol and the activity of KLF1 was induced by adding tamoxifen. Activation of
KLF1 from day 10 accelerated erythroid differentiation and maturation with an
increase in the proportion of erythroblasts, a higher level of expression of erythroid
genes associated with maturation and an apparently more robust morphology.
However, KLF1 activation had an anti-proliferation effect resulting in significantly
less cell generated overall and HPLC analysis demonstrated that KLF1-activated cells
expressed higher levels of embryonic globin compared to control iPSCs-derived cells.
Many of the effects that were observed when KLF1 was activated from day 10 were
not observed when activated from day 18. We therefore concluded that activation of
exogenous KLF1 is able to promote erythroid cell production and maturation in
progenitors (day 10) but not at the later stage of erythropoiesis (day 18). We
hypothesised that KLF1 might require a co-factor to regulate RBC maturation and
adult globin expression at the later stage of erythropoiesis.
The TF, B-cell lymphoma/leukaemia 11a (BCL11A), plays a key role in the
suppression of foetal globin expression, thereby completing globin switching to adult
globin. Preliminary data showed that iPSC-derived erythroid cells were able to express
adult globin when transduced with a BCL11A-expressing lentiviral-vector. Based on
that finding we then generated an iPSC line expressing tamoxifen-inducible BCL11AERT2
and KLF1-ERT2 fusion proteins, applied this iBK iPSC line to our differentiation
protocol. Activation of both TFs from day 18 slightly increased the expression of genes
associated with RBC maturation and the inclusion of BCL11A appeared to eliminate
the anti-proliferation effect of KLF1. Most importantly, activation of both BCL11A
and KLF1 from day 18 of the differentiation protocol increased the production of α-
globin (foetal / adult globin) indicating that some definitive-like erythroid cells might
be generated by activation of both TFs at the later stage of erythroid differentiation.
Collectively, these findings demonstrate that enforced expression of erythroid TFs
could be a useful strategy to enhance RBC maturation from iPSCs
A role for mospd1 in mesenchymal stem cell proliferation and differentiation
Mesenchymal stem cells (MSCs) isolated from many tissues including bone marrow and fat can be expanded in vitro and can differentiate into a range of different cell types such as bone, cartilage, and adipocytes. MSCs can also exhibit immunoregulatory properties when transplanted but, although a number of clinical trials using MSCs are in progress, the molecular mechanisms that control their production, proliferation, and differentiation are poorly understood. We identify MOSPD1 as a new player in this process. We generated MOSPD1‐null embryonic stem cells (ESCs) and demonstrate that they are deficient in their ability to differentiate into a number of cell lineages including osteoblasts, adipocytes, and hematopoietic progenitors. The self‐renewal capacity of MOSPD1‐null ESCs was normal and they exhibited no obvious defects in early germ layer specification nor in epithelial to mesenchymal transition (EMT), indicating that MOSPD1 functions after these key steps in the differentiation process. Mesenchymal stem cell (MSC)‐like cells expressing CD73, CD90, and CD105 were generated from MOSPD1‐null ESCs but their growth rate was significantly impaired implying that MOSPD1 plays a role in MSC proliferation. Phenotypic deficiencies exhibited by MOSPD1‐null ESCs were rescued by exogenous expression of MOSPD1, but not MOSPD3 indicating distinct functional properties of these closely related genes. Our in vitro studies were supported by RNA‐sequencing data that confirmed expression of Mospd1 mRNA in cultured, proliferating perivascular pre‐MSCs isolated from human tissue. This study adds to the growing body of knowledge about the function of this largely uncharacterized protein family and introduces a new player in the control of MSC proliferation and differentiation. Stem Cells 2015;33:3077–308
Enforced Expression of HOXB4 in Human Embryonic Stem Cells Enhances the Production of Hematopoietic Progenitors but Has No Effect on the Maturation of Red Blood Cells
We have developed a robust, Good Manufacturing Practice-compatible differentiation protocol capable of producing scalable quantities of red blood cells (RBCs) from human pluripotent stem cells (hPSCs). However, translation of this protocol to the clinic has been compromised because the RBCs produced are not fully mature; thus, they express embryonic and fetal, rather than adult globins, and they do not enucleate efficiently. Based on previous studies, we predicted that activation of exogenous HOXB4 would increase the production of hematopoietic progenitor cells (HPCs) from hPSCs and hypothesized that it might also promote the production of more mature, definitive RBCs. Using a tamoxifen-inducible HOXB4-ERT2 expression system, we first demonstrated that activation of HOXB4 does increase the production of HPCs from hPSCs as determined by colony-forming unit culture activity and the presence of CD43+CD34+ progenitors. Activation of HOXB4 caused a modest, but significant, increase in the proportion of immature CD235a+/CD71+ erythroid cells. However, this did not result in a significant increase in more mature CD235a+/CD71− cells. RBCs produced in the presence of enhanced HOXB4 activity expressed embryonic (ε) and fetal (γ) but not adult (β) globins, and the proportion of enucleated cells was comparable to that of the control cultures. We conclude that programming with the transcription factor HOXB4 increases the production of hematopoietic progenitors and immature erythroid cells but does not resolve the inherent challenges associated with the production of mature adult-like enucleated RBCs
Expression-independent gene trap vectors for random and targeted mutagenesis in embryonic stem cells
Promoterless gene trap vectors have been widely used for high-efficiency gene targeting and random mutagenesis in embryonic stem (ES) cells. Unfortunately, such vectors are only effective for genes expressed in ES cells and this has prompted the development of expression-independent vectors. These polyadenylation (poly A) trap vectors employ a splice donor to capture an endogenous gene's polyadenylation sequence and provide transcript stability. However, the spectrum of mutations generated by these vectors appears largely restricted to the last intron of target loci due to nonsense-mediated mRNA decay (NMD) making them unsuitable for gene targeting applications. Here, we present novel poly A trap vectors that overcome the effect of NMD and also employ RNA instability sequences to improve splicing efficiency. The set of random insertions generated with these vectors show a significantly reduced insertional bias and the vectors can be targeted directly to a 5′ intron. We also show that this relative positional independence is linked to the human β-actin promoter and is most likely a result of its transcriptional activity in ES cells. Taken together our data indicate that these vectors are an effective tool for insertional mutagenesis that can be used for either gene trapping or gene targeting
The incidence, aetiology and outcome of acute seizures in children admitted to a rural Kenyan district hospital
<p>Abstract</p> <p>Background</p> <p>Acute seizures are a common cause of paediatric admissions to hospitals in resource poor countries and a risk factor for neurological and cognitive impairment and epilepsy. We determined the incidence, aetiological factors and the immediate outcome of seizures in a rural malaria endemic area in coastal Kenya.</p> <p>Methods</p> <p>We recruited all children with and without seizures, aged 0–13 years and admitted to Kilifi District hospital over 2 years from 1<sup>st </sup>December 2004 to 30<sup>th </sup>November 2006. Only incident admissions from a defined area were included. Patients with epilepsy were excluded. The population denominator, the number of children in the community on 30<sup>th </sup>November 2005 (study midpoint), was modelled from a census data.</p> <p>Results</p> <p>Seizures were reported in 900/4,921(18.3%) incident admissions and at least 98 had status epilepticus. The incidence of acute seizures in children 0–13 years was 425 (95%CI 386, 466) per 100,000/year and was 879 (95%CI 795, 968) per 100,000/year in children <5 years. This incidence data may however be an underestimate of the true incidence in the community. Over 80% of the seizures were associated with infections. Neonatal infections (28/43 [65.1%]) and falciparum malaria (476/821 [58.0%]) were the main diseases associated with seizures in neonates and in children six months or older respectively. Falciparum malaria was also the main illness (56/98 [57.1%]) associated with status epilepticus. Other illnesses associated with seizures included pyogenic meningitis, respiratory tract infections and gastroenteritis. Twenty-eight children (3.1%) with seizures died and 11 surviving children (1.3%) had gross neurological deficits on discharge. Status epilepticus, focal seizures, coma, metabolic acidosis, bacteraemia, and pyogenic meningitis were independently associated with mortality; while status epilepticus, hypoxic ischaemic encephalopathy and pyogenic meningitis were independently associated with neurological deficits on discharge.</p> <p>Conclusion</p> <p>There is a high incidence of acute seizures in children living in this malaria endemic area of Kenya. The most important causes are diseases that are preventable with available public health programs.</p
- …